Ad-hoc disclosure of January 13, 2022

  • Disclosure of Insider Information as per Article 17 of MAR
  • Wacker Chemie AG / Financial Results
  • EBITDA for 2021 expected to be above guidance and market expectations

Munich, Jan 13, 2022

According to preliminary evaluations, Wacker Chemie AG anticipates EBITDA (earnings before interest, taxes, depreciation and amortization) of about €1.5 billion for 2021, with sales coming in at about €6.2 billion. That represents an EBITDA 7 percent above the upper end of recent full-year EBITDA guidance of between €1.2 billion and €1.4 billion and 9 percent above current average market expectations of €1.37 billion (source: Vara Research, Jan. 13, 2022).

WACKER intends to publish preliminary figures for 2021 by end of January 2022.

Contact

Wacker Chemie AG
Hanns-Seidel-Platz 4
D-81737 München

Jörg Hoffmann
Tel. +49 89 6279-1633
Email investor.relations@wacker.com

Additional Information

ISIN: DE000WCH8881
WKN: WCH888
Deutsche Boerse : WCH
Ticker Bloomberg CHM/WCK.GR
Ticker Reuters CHE/WCHG.DE
Listing: Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), Official Market (Prime Standard)

Disclaimer:

This publication contains forward-looking statements based on assumptions and estimates of WACKER’s Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

This document includes supplemental financial measures (not clearly defined in the applicable financial reporting framework) that are or may be alternative performance measures (APM). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of WACKER’s net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently. Explanations of financial measures used can be found in the Annual Report of Wacker Chemie AG which is available for download under www.wacker.com.